Nicholas Galakatos, 10% Owner at ARYx Therapeutics, Inc. (ARYX), bought 1,787,710 shares at $2.20 ($3.9M) on 2008-11-14, disclosed to the SEC on 2008-11-17.
Open-market purchase of $3.9M ARYX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |